NCT07834840

Brief Summary

The goal of this interventional study is to learn whether dietary education and intervention can reduce blood uric acid levels in patients with gout. The main questions this study aims to answer are:

  • Can dietary education and intervention reduce gout-related clinical laboratory results?
  • Can dietary education and intervention improve BMI and SBP/DBP in participants with gout? In this study, participants will be divided into three groups, including a control group, and their outcomes compared, in order to determine whether a low-purine (low-uric-acid) diet and a DASH diet are effective in reducing blood uric acid levels in participants with gout. Participants will:
  • Participate in the study for a total of 2 years, receiving dietary education and intervention according to their assigned group throughout this period
  • Complete surveys, physical measurements, and receive dietary education once every 6 months
  • Receive dietary education by phone and through an app, and complete surveys, once every month

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
104mo left

Started Mar 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress15%
Mar 2025May 2035

Study Start

First participant enrolled

March 26, 2025

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

September 17, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 22, 2026

Completed
8.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2035

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2035

Last Updated

September 22, 2026

Status Verified

September 1, 2026

Enrollment Period

9.8 years

First QC Date

September 17, 2026

Last Update Submit

September 17, 2026

Conditions

Keywords

GoutDASHGout in Dietlow purine diet

Outcome Measures

Primary Outcomes (1)

  • Uric Acid Level

    Measured in serum

    Baseline, At 12-months, At 24-months

Secondary Outcomes (4)

  • Body Mass Index (kg/m^2)

    Baseline, At 6-months, At 12-months, At 18-months, At 24-months

  • Systolic Blood Pressure(mmHg)

    Baseline, At 6-months, At 12-months, At 18-months, At 24-months

  • Diastolic Blood Pressure (mmHg)

    Baseline, At 6-months, At 12-months, At 18-months, At 24-months

  • Change in Purine-rich food Intake

    Baseline, At 6-months, At 12-months, At 18-months, At 24-months

Study Arms (3)

Usual Diet and lifestyle

NO INTERVENTION

Participants will maintain their usual diet and lifestyle without receiving a specific dietary intervention.

Low-Uric acid Diet

EXPERIMENTAL

The low-uric-acid diet is designed to provide a higher daily purine intake than a low-purine diet. Participants will receive dietary education to limit the consumption of red meat, organ meats, seafood, and alcohol, while emphasizing plant-based foods such as vegetables, fruits, whole grains, and legumes.

Behavioral: Low-Uric acid Diet

DASH Diet

EXPERIMENTAL

\*\*DASH Diet:\*\* Participants will be encouraged to consume lean meats, selected fish, vegetables, fruits, whole grains, low-fat dairy products, nuts, and legumes. They will also be asked to limit their intake of sodium, saturated fat, refined carbohydrates, and fatty meats.

Behavioral: DASH Diet

Interventions

DASH DietBEHAVIORAL

Participants will receive monthly reminders about dietary education and complete questionnaires to assess adherence to the assigned diet. * Every 6 months, participants will undergo measurements of body composition using bioelectrical impedance analysis, waist and hip circumference, and blood pressure during their scheduled outpatient visits to assess their health status. * Blood samples will be collected annually to assess the effects of the dietary intervention and education on participants' health. * Participants will receive KRW 40,000 in compensation for study participation every 12 months.

DASH Diet

Participants will receive monthly reminders about dietary education and complete questionnaires to assess adherence to the assigned diet. * Every 6 months, participants will undergo measurements of body composition using bioelectrical impedance analysis, waist and hip circumference, and blood pressure during their scheduled outpatient visits to assess their health status. * Blood samples will be collected annually to assess the effects of the dietary intervention and education on participants' health. * Participants will receive KRW 40,000 in compensation for study participation every 12 months.

Low-Uric acid Diet

Eligibility Criteria

Age19 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Currently receiving urate-lowering therapy at this hospital
  • Male, aged 19 years or older, with a history of at least one gout flare

You may not qualify if:

  • Unwilling or unable to provide informed consent
  • Life expectancy of less than 2years due to comorbid conditions
  • Refusal of urate-lowering therapy
  • Estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73m² or less (diagnosed with chronic kidney disease stage 3B or higher)
  • E. Diagnosis of chronic obstructive pulmonary disease (COPD) or asthma within the past 6 months
  • F. History of gastrointestinal disease (including inflammatory bowel disease, malabsorption, gastric bypass surgery, or major bowel resection)
  • G. Currently receiving chemotherapy for cancer treatment
  • H. Diagnosis of myocardial infarction, heart failure, or angina, or history of coronary artery bypass surgery or angioplasty, within the past 6 months
  • I. Any other condition that, in the investigator's judgment, makes the participant unsuitable for this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ajou University Hospital

Suwon, Gyeonggi-do, 16499, South Korea

Location

Related Publications (2)

  • Yokose C, McCormick N, Choi HK. The role of diet in hyperuricemia and gout. Curr Opin Rheumatol. 2021 Mar 1;33(2):135-144. doi: 10.1097/BOR.0000000000000779.

  • Yokose C, McCormick N, Rai SK, Lu N, Curhan G, Schwarzfuchs D, Shai I, Choi HK. Effects of Low-Fat, Mediterranean, or Low-Carbohydrate Weight Loss Diets on Serum Urate and Cardiometabolic Risk Factors: A Secondary Analysis of the Dietary Intervention Randomized Controlled Trial (DIRECT). Diabetes Care. 2020 Nov;43(11):2812-2820. doi: 10.2337/dc20-1002. Epub 2020 Sep 2.

MeSH Terms

Conditions

Gout

Interventions

Dietary Approaches To Stop Hypertension

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesCrystal ArthropathiesRheumatic DiseasesPurine-Pyrimidine Metabolism, Inborn ErrorsMetabolism, Inborn ErrorsGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to one of three groups: the control group, the low-urate diet group, or the DASH diet group. Participants will receive diet education according to their assigned group and undergo the corresponding dietary intervention throughout the study period.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 17, 2026

First Posted

September 22, 2026

Study Start

March 26, 2025

Primary Completion (Estimated)

January 1, 2035

Study Completion (Estimated)

May 1, 2035

Last Updated

September 22, 2026

Record last verified: 2026-09

Locations